Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6693099B2 · kind B2 · utility
52Cited by
67References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2000 |
| Grant date | Feb 17, 2004 |
| Priority date | — |
| Expiry date | Dec 19, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted heterocyclic compounds for treating multidrug resistance are disclosed. Compositions and methods of use for the substituted heterocyclic compounds are disclosed. Suitable substituted heterocyclic compounds include:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.